Search results
Results from the WOW.Com Content Network
When there is a shortage of FDA-approved, brand-name medication – like with GLP-1 drugs Ozempic and Wegovy – the FDA says it allows compounding pharmacies to make alternative medications that ...
How and why the drugs have such wide-ranging health benefits is subject to further research, and the GLP-1 drugs were found to increase risks of some conditions, including kidney stones and low ...
New research published in has found evidence that the use of semaglutide medications, like Ozempic may help reduce the risk of obesity-associated cancers in people with type 2 diabetes.
There’s still a lot we don’t know about how and why Ozempic and its fellow glucagon-like peptide-1 agonist meds (commonly referred to as GLP-1s) impact the brain—but we do know that they ...
The review authors noted that research into the potential brain benefits of GLP-1 medications needs more research but are optimistic about the future of these drugs in how they may boost brain health.
Semaglutide is not recommended for people with a personal or family history of thyroid cancer (in particular, medullary thyroid cancer) because the medication may increase the risk for that ...
Ozempic was FDA-approved in December 2017 as a diabetes drug. It’s prescribed off-label for weight loss. This is when a doctor prescribes a drug for something it hasn’t been approved for ...
Ozempic is currently only FDA-approved to treat patients with type 2 diabetes, but can be prescribed off-label for weight loss, meaning a doctor prescribes a drug to treat a different condition ...